Storage, expansion and future therapeutic applications of tissues and stem cells


	Company Investor Relations Stem Cell Storage Cell Expansion Cell Therapies Research and Development Company News Scientific News Contact
	Hot News Umbilical cord blood stem cell storage should increase in Europe(11/09/2007) Brussels September 11 2007. - The number of stored stem cells derived from umbilical cord blood is significantly lower in Europe than compared with practices in the United States. Umbilical cord blood stem cells have been used over the years in an increasing number of treatments including leukemia, myelodysplastic syndrome, lymphomas, inherited red cell cancers and more. Scientists and medical specialists confirm that currently more than 60 diseases have been treated while using stem cells. Portuguese child successfully treated with private stored stem cells(16/07/2007) Porto / Brussels July 16 2007. - A child suffering from a severe T-cell (CD8+) immune deficiency syndrome has been treated successfully with umbilical cord blood stem cells in Portugal. The child’s congenital dificiency was clinically diagnosed in Coimbra. The transplantation treatment was performed at the Bone Marrow Transplantation Unit, lead by director Dr. Pedro Pimentel at the Oncology Institute in Porto. Dr. Alzira Carvalhais is the head of the Immuno-Hemato Therapy Department.	About Cryo-Save Cryo-Save is the leading private family bank of cord blood stem cells in Europe, with more than 70.000 samples stored. The Company was established in 2000, is headquartered in The Netherlands, and owns or has access to, operating laboratory and storage facilities in Belgium, Germany and Dubai. Cryo-Save's services are available in 37 countries across three continents (Europe, Asia, Africa). Cryo-Save is a founding member of the International Tissue Engineering Research Association, an international forum of scientists and researchers specialised in stem cells and tissue repair. Together with 5 universities in Europe and the Fraunhofer Institute, Cryo-Save has been selected to conduct fundamental research in the field of cryopreservation techniques for stem cells in an EU funded Framework Program called CRYSTAL. Cryo-Save is focused on the collection and storage of ADULT stem cells derived from cord blood, umbilical and adipose tissue. The Group has never been, and does not intend to become, involved in the storage or expansion of embryonic stem cells.
	Europe's leading family stem cell bank - 4 laboratories - 37 countries - 3 continents	Company \| Investor Relations \| Stem Cell Storage \| Cell Expansion \| Cell Therapies \| Research and Development \| Company News \| Scientific News \| Contact Use of this website signifies your agreement to the Disclaimer. ©2008 Cryo-Save Group N.V. All rights reserved.

web metrics